alpha 1-adrenoceptor subtype selectivity: Molecular modelling and theoretical quantitative structure-affinity relationships

被引:25
|
作者
DeBenedetti, PG [1 ]
Fanelli, F [1 ]
Menziani, MC [1 ]
Cocchi, M [1 ]
Testa, R [1 ]
Leonardi, A [1 ]
机构
[1] RECORDATI SPA,FARMACEUT R&D DIV,I-20148 MILAN,ITALY
关键词
D O I
10.1016/S0968-0896(97)00007-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study constitutes a preliminary rationalization, at the molecular level, of antagonist selectivity towards the three cloned alpha 1-adrenergic receptor (alpha 1-AR) subtypes. Molecular dynamics simulations allowed a structural/dynamics analysis of the seven alpha-helix-bundle models of the bovine alpha 1a-, hamster alpha 1b-, and rat alpha 1d-AR subtypes. The results showed that the transmembrane domains of these subtypes have different dynamic behaviours and different topographies of the binding sites, which are mainly constituted by conserved residues. In particular, the alpha 1a-AR binding site is more flexible and topographically different with respect to the other two subtypes. The results of the theoretical structural/dynamics analysis of the isolated receptors are consistent with the binding affinities of the 16 antagonists tested towards the three cloned alpha 1a-AR subtypes. Moreover, the theoretical quantitative structure-affinity relationships obtained from the antagonist-receptor interaction models further corroborates the hypothesis that selectivity towards one preferential subtype is mainly modulated by receptor and/or ligand distortion energies. In other words, subtype selectivity seems to be mainly guided by the dynamic complementarity (induced fit) between ligand and receptor. On the basis of the quantitative models presented it is possible to predict both affinities and selectivities of putative alpha 1-AR ligands as well as to estimate the theoretical alpha 1-AR subtype affinities and selectivities of existing antagonists. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:809 / 816
页数:8
相关论文
共 50 条
  • [1] α1-adrenoceptor subtype selectivity and lower urinary tract symptoms
    Schwinn, DA
    Price, DT
    Narayan, P
    MAYO CLINIC PROCEEDINGS, 2004, 79 (11) : 1423 - 1434
  • [2] Tamsulosin:: α1-adrenoceptor subtype-selectivity and comparison with terazosin
    Muramatsu, I
    Taniguchi, T
    Okada, K
    JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (03): : 331 - 335
  • [3] ADTX1, A NEW PEPTIDIC □1-ADRENOCEPTOR ANTAGONIST WITH HIGH AFFINITY AND SELECTIVITY FOR HUMAN □1A-ADRENOCEPTOR SUBTYPE: PHARMACOLOGICAL CHARACTERIZATION
    Gilles, N.
    Lluel, P.
    Rekik, M.
    Guerard, M.
    Palea, S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 210 - 210
  • [4] Computer modeling of size and shape descriptors of α1-adrenergic receptor antagonists and quantitative structure-affinity/selectivity relationships
    Montorsi, M
    Menziani, MC
    Cocchi, M
    Fanelli, F
    De Benedetti, PG
    METHODS, 1998, 14 (03) : 239 - 254
  • [5] α1-adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213)
    Tatemichi, S
    Kobayashi, K
    Maezawa, A
    Kobayashi, M
    Yamazaki, Y
    Shibata, N
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2006, 126 : 209 - 216
  • [6] Human α1-adrenoceptor subtype selectivity of substituted homobivalent 4-aminoquinolines
    Chen, Junli
    Campbell, Adrian P.
    Urmi, Kaniz F.
    Wakelin, Laurence P. G.
    Denny, William A.
    Griffith, Renate
    Finch, Angela M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (21) : 5910 - 5916
  • [7] Vascular α1-adrenoceptor subtype selectivity and α1-blocker-induced orthostatic hypotension
    Take, H
    Shibata, K
    Awaji, T
    Hirasawa, A
    Ikegaki, I
    Asano, T
    Takada, T
    Tsujimoto, G
    JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 77 (01): : 61 - 70
  • [8] ALPHA(1)-ADRENOCEPTOR SELECTIVITY - CLINICAL OR THEORETICAL BENEFIT
    LEPOR, H
    BRITISH JOURNAL OF UROLOGY, 1995, 76 : 57 - 61
  • [9] Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists
    Martin, DJ
    Lluel, P
    Guillot, E
    Coste, A
    Jammes, D
    Angel, I
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (01): : 228 - 235
  • [10] 1,3-Dioxolane-based ligands incorporating a lactam or imide moiety: Structure-affinity/activity relationship at α1-adrenoceptor subtypes and at 5-HT1A receptors
    Franchini, Silvia
    Prandi, Adolfo
    Baraldi, Annamaria
    Sorbi, Claudia
    Tait, Annalisa
    Buccioni, Michela
    Marucci, Gabriella
    Cilia, Antonio
    Pirona, Lorenza
    Fossa, Paola
    Cichero, Elena
    Brasili, Livio
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (09) : 3740 - 3751